<DOC>
	<DOCNO>NCT01514110</DOCNO>
	<brief_summary>The purpose study determine dose limit toxicity ( DLT ) maximum tolerate dose ( MTD ) RAD001 , well assess tumor response overall survival .</brief_summary>
	<brief_title>Gastric Cancer RAD001 Study</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Histologically cytologically proven adenocarcinoma stomach . Patients adenocarcinoma gastroesophageal junction eligible majority tumor bulk junction . Metastatic Locoregionally advance disease Patients must measurable disease , define least one lesion accurately measure least one dimension ( long diameter record ) &gt; = 20 mm conventional technique &gt; = 10 mm spiral CT /MRI scan . See section 11.2 evaluation measurable disease . Age &gt; = 18 year . Life expectancy great 12 week . ECOG performance status &lt; = 2 ( Karnofsky &gt; = 60 % ) . Patients receive one line palliative chemotherapy allow , provide ( ) prior chemotherapy contain taxane , cisplatin carboplatin ; ( ii ) 4 week elapse prior start current study treatment , ( iii ) recover adverse event due previous treatment [ except alopecia ] . Patients radiotherapy major surgery within 4 week prior enter study recover adverse event due treatment administer 4 week earlier . Patients CYP3A4 modifier exclude study Patients know brain metastasis . History allergic reaction attribute compound similar chemical biologic composition RAD001 . Significant cardiovascular disease include unstable angina pectoris , uncontrolled hypertension , congestive heart failure relate primary cardiac disease , condition require antiarrhythmic therapy , ischemic severe valvular heart disease , myocardial infarction within 6 month prior trial entry . Patients severe concurrent medical illness severe impairment lung function exclude study RAD001 . Uncontrolled intercurrent , limited , ongoing active infection , psychiatric illness/social situation would limit compliance study requirement . Poorly control diabetes mellitus High LDL cholesterol triglyceride level Preexisting neuropathy &gt; = grade 2 Patients history second malignancy eligible disease free least 5 year deem investigator low risk recurrence . Par8entswith follow cancer eligible diagnose treat within past 5 year : cervical carcinoma situ , melanoma situ , basal cell squamous cell carcinoma skin Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>